| Literature DB >> 25110551 |
Solène Le Maux1, Saïd Bouhallab2, Linda Giblin3, André Brodkorb3, Thomas Croguennec2.
Abstract
Ligand-binding properties of β-lactoglobulin (β-lg) are well documented, but the subsequent biological functions are still unclear. Focusing on fatty acids/β-lg complexes, the structure-function relationships are reviewed in the light of the structural state of the protein (native versus non-native aggregated proteins). After a brief description of β-lg native structure, the review takes an interest in the binding properties of native β-lg (localization of binding sites, stoichiometry, and affinity) and the way the interaction affects the biological properties of the protein and the ligand. The binding properties of non-native aggregated forms of β-lg that are classically generated during industrial processing are also related. Structural changes modify the stoichiometry and the affinity of β-lg for fatty acids and consequently the biological functions of the complex. Finally, the fatty acid-binding properties of other whey proteins (α-lactalbumin, bovine serum albumin) and some biological properties of the complexes are also addressed. These proteins affect β-lg/fatty acids complex in whey given their competition with β-lg for fatty acids.Entities:
Keywords: Binding properties; Biological properties; Bovine β-lactoglobulin; Fatty acid; Protein structure
Year: 2014 PMID: 25110551 PMCID: PMC4121524 DOI: 10.1007/s13594-014-0160-y
Source DB: PubMed Journal: Dairy Sci Technol ISSN: 1958-5586
Fig. 1A schematic view of the main-chain fold of bovine β-lg in interaction with linoleic acid in its central cavity. The graphic was performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311, http://www.cgl.ucsf.edu/chimera). RCSB PDB code 4DQ4 (Loch et al. 2012b)
Parameters of the interactions between β-lactoglobulin and various fatty acids at different pH
| Common name | pH | βlg (μM) | Method |
|
|
|
|
|
| Reference | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Caprylic acid | C8:0 | 6 | 5 to 10 | F (ANS) | <3 | 102 | Collini et al. | ||||
| Caprylic acid | C8:0 | 7 | 5 to 10 | F (ANS) | <7 | 102 | Collini et al. | ||||
| Caprylic acid | C8:0 | 8 | 5 to 10 | F (ANS) | 2.6 | 104 | Collini et al. | ||||
| Caprylic acid | C8:0 | 7.5 | 20 | F | 0.7 | 1.1 | 104 | Loch et al. | |||
| Capric acid | C10:0 | 7.5 | 20 | F | 0.6 | 6 | 103 | Loch et al. | |||
| Lauric acid | C12:0 | 6 | 5 to 10 | F (ANS) | 2.4 | 104 | Collini et al. | ||||
| Lauric acid | C12:0 | 7 | 5 to 10 | F (ANS) | 1.6 | 105 | Collini et al. | ||||
| Lauric acid | C12:0 | 8 | 5 to 10 | F (ANS) | 1.4 | 105 | Collini et al. | ||||
| Lauric acid | C12:0 | 7 | 10 to 60 | F | 0.9 | 1.4 | 106 | Frapin et al. | |||
| Lauric acid | C12:0 | 7.5 | 50 to 100 | ITC | 0.7 | 1.7 | 105 | Loch et al. | |||
| Lauric acid | C12:0 | 7.5 | 100 | ITC | 0.6 | 2.48 | 105 | Loch et al. | |||
| Lauric acid | C12:0 | 7.5 | 100 | ITC | 0.2 | 1.5 | 105 | Loch et al. | |||
| Lauric acid | C12:0 | 7.4 | 200 | EP | 1 | 5.2 | 104 | 2 | 1.1 | 103 | Spector and Fletcher |
| Lauric acid | C12:0 | 7.4 | 200 | EP | 1 | 4 | 104 | 24 | 0.1 | 103 | Spector and Fletcher |
| Myristic acid | C14:0 | 3 | 10 to 60 | F | 0 | Frapin et al. | |||||
| Myristic acid | C14:0 | 7 | 10 to 60 | F | 0.3 | 3 | 106 | Frapin et al. | |||
| Myristic acid | C14:0 | 8.5 | 12 | ESI-MS | 1.9 | 105 | Liu et al. | ||||
| Myristic acid | C14:0 | 7.5 | 50 to 100 | ITC | 0.6 | 7.8 | 105 | Loch et al. | |||
| Myristoleic acid | C14:1 | 7 | 10 to 60 | F | 0.8 | 6.3 | 106 | Frapin et al. | |||
| Palmitic acid | C16:0 | 6 | 5 to 10 | F (ANS) | 6.6 | 104 | Collini et al. | ||||
| Palmitic acid | C16:0 | 7 | 5 to 10 | F (ANS) | 4.7 | 105 | Collini et al. | ||||
| Palmitic acid | C16:0 | 8 | 5 to 10 | F (ANS) | 5.1 | 105 | Collini et al. | ||||
| Palmitic acid | C16:0 | 3 | 10 to 60 | F | 0 | Frapin et al. | |||||
| Palmitic acid | C16:0 | 7 | 10 to 60 | F | 0.9 | 1 | 107 | Frapin et al. | |||
| Palmitic acid | C16:0 | 8.5 | 12 | ESI-MS | 3.8 | 105 | Liu et al. | ||||
| Palmitic acid | C16:0 | 7.5 | 40 to 60 | ITC | 1.1 | 20 | 105 | Loch et al. | |||
| Palmitic acid | C16:0 | 6.5 | 10 to 150 | F | 1 | 2 | 106 | Narayan and Berliner | |||
| Palmitic acid | C16:0 | 7 | 10 to 150 | F | 1 | 1.7 | 106 | Narayan and Berliner | |||
| Palmitic acid | C16:0 | 8.5 | 10 to 150 | F | 1 | 2.5 | 106 | Narayan and Berliner | |||
| Palmitic acid | C16:0 | 7.2 | 41.5 | EP | 1 | 4.2 | 106 | Perez et al. | |||
| Palmitic acid | C16:0 | 8.4 to 2.1 | 1,500 | NMR | 1 | Ragona et al. | |||||
| Palmitic acid | C16:0 | 7.4 | 200 | EP | 1 | 6.6 | 105 | 6 | 7.1 | 103 | Spector and Fletcher |
| Palmitic acid | C16:0 | 7.4 | 200 | EP | 1 | 7 | 105 | 24 | 1.6 | 103 | Spector and Fletcher |
| Palmitic acid | C16:0 | 7 | 1 to 200 | UF | 1 | 2.3 | 105 | 23 | 0.4 | 104 | Wang et al. |
| Palmitic acid | C16:0 | 7 | 20 | F | 1.2 | 2 | 106 | Wang et al. | |||
| Palmitic acid | C16:0 | 8 | 5 | F | 0.8 | 2.3 | 107 | Yang et al. | |||
| Palmitoleic acid | C16:1 | 7 | 10 to 60 | F | 0.8 | 3.9 | 106 | Frapin et al. | |||
| Stearic acid | C18:0 | 7 | 10 to 60 | F | 0.9 | 8.3 | 106 | Frapin et al. | |||
| Stearic acid | C18:0 | 8.5 | 12 | ESI-MS | 1.6 | 106 | Liu et al. | ||||
| Stearic acid | C18:0 | 7.4 | 200 | EP | 1 | 1.6 | 105 | 2 | 4.2 | 103 | Spector and Fletcher |
| Stearic acid | C18:0 | 7.4 | 200 | EP | 1 | 1.8 | 105 | 4 | 17 | 103 | Spector and Fletcher |
| Stearic acid | C18:0 | 7.4 | 200 | EP | 1 | 1.6 | 105 | 6 | 12 | 103 | Spector and Fletcher |
| Stearic acid | C18:0 | 7.4 | 200 | EP | 1 | 1.5 | 105 | 12 | 5.9 | 103 | Spector and Fletcher |
| Stearic acid | C18:0 | 7.4 | 200 | EP | 1 | 1.9 | 105 | 24 | 2.5 | 103 | Spector and Fletcher |
| Oleic acid | C18:1 | 3 | 10 to 60 | F | 0 | Frapin et al. | |||||
| Oleic acid | C18:1 | 7 | 10 to 60 | F | 0.8 | 7.7 | 106 | Frapin et al. | |||
| Oleic acid | C18:1 | 7.4 | 163 and 1,630 | FTIR | ∼8 | Lišková et al. | |||||
| Oleic acid | C18:1 | 7.5 | ITC | 0.8 | 9.7 | 105 | Loch et al. | ||||
| Oleic acid | C18:1 | 7.2 | 41.5 | EP | 1 | 2.3 | 106 | Perez et al. | |||
| Oleic acid | C18:1 | 7.4 | 200 | EP | 1 | 0.4 | 105 | 24 | 1.3 | 103 | Spector and Fletcher |
| Elaidic acid | C18:1 | 7 | 10 to 60 | F | 0.8 | 6.7 | 106 | Frapin et al. | |||
| Rumenic acid (CLA) | C18:2 | 7 | 1 | F | 2.5 | 3.7 | 106 | Jiang and Liu | |||
| Linoleic acid | C18:2 | 7 | 10 to 60 | F | 0.8 | 5.3 | 106 | Frapin et al. | |||
| Linoleic acid | C18:2 | 7.4 | 163 | ITC | 0.6 | 2.7 | 105 | 5.8 | 5.9 | 103 | Le Maux et al. |
| Linoleic acid | C18:2 | 7.5 | ITC | 0.6 | 9 | 105 | Loch et al. | ||||
| Linolelaidic acid | C18:2 | 7 | 10 to 60 | F | 0.9 | 3.3 | 106 | Frapin et al. | |||
| γ-Linolenic acid | C18:3 | 7 | 10 to 60 | F | 0.9 | 7.7 | 106 | Frapin et al. | |||
| Linolenic | C18:3 | 7 | 10 to 60 | F | 0.9 | 5.9 | 106 | Frapin et al. | |||
|
| C18:4 | 3 | 1 to 20 | F | 0.2 | 4.8 | 107 | Dufour et al. | |||
|
| C18:4 | 7 | 1 to 20 | F | 0.8 | 3.6 | 107 | Dufour et al. | |||
| Arachidic acid | C20:0 | 7 | 10 to 60 | F | 0.9 | 2.5 | 106 | Frapin et al. | |||
| Arachidonic acid | C20:4 | 7 | 10 to 60 | F | 0.8 | 3 | 106 | Frapin et al. | |||
| Docosahexaenoic acid | C22:6 | 7 | 1 | F | 2.7 | 6.8 | 105 | Zimet and Livney |
K a, affinity constant; n, stoichiometry (mole ligand/mole protein; n 1, K a1 and n 2, K a2 being the binding parameters for the first and second set of binding sites, respectively). Caprylic acid, octanoic acid; capric acid, decanoic acid; lauric acid, dodecanoic acid; myristic acid, tetradecanoic acid; myristoleic acid, cis-9-tetradecenoic acid; palmitic acid, hexadecanoic acid; palmitoleic acid, cis-9-hexadecenoic acid; stearic acid, octadecanoic acid; oleic acid, cis-9-octadecenoic acid; elaidic acid, trans-9-octadecenoic acid; rumenic acid (CLA), cis,trans-9,11-octadecadienoic acid; linoleic acid, cis,cis-9,12-octadecadienoic acid; linolelaidic acid, trans,trans-9,12-octadecadienoic acid; γ-linolenic acid, cis,cis,cis-6,9,12-octadecatrienoic acid; linolenic acid, cis,cis,cis-9,12,15-octadecatrienoic acid; cis-parinaric acid, cis,trans,trans,cis-9,11,13,15-octadecatetraenoic acid; arachidic acid, eicosanoic acid; arachidonic acid, trans,trans,trans,trans-5,8,11,14-icosatetraenoic acid; docosahexaenoic acid, all cis-4,7,10,13,16,19-docosahexaenoic acid
F fluorescence, ITC isothermal titration calorimetry, EP equilibrium partition, ESI-MS electrospray ionization mass spectrometry, NMR nuclear magnetic resonance, UF ultrafiltration, FTIR fourier transform infrared spectroscopy (different methods used to study the interactions)